Table 4.
Immunosuppression use, by diagnosis and agea
| Pediatric |
P value | Adult |
P value | |||
|---|---|---|---|---|---|---|
| IgAN n = 173 |
IgAV n = 112 |
IgAN n = 333 |
IgAV n = 49 |
|||
| n (%) | n (%) | n (%) | n (%) | |||
| Number of medications usedb | ||||||
| 0 | 85 (49.7%) | 27 (24.1%) | <0.001 | 147 (44.1%) | 6 (12.2%) | <0.001 |
| 1 | 44 (25.7%) | 44 (39.3%) | 125 (37.5%) | 27 (55.1%) | ||
| 2 | 34 (19.9%) | 37 (33.0%) | 43 (12.9%) | 12 (24.5%) | ||
| 3 | 8 (4.7%) | 2 (1.8%) | 15 (4.5%) | 3 (6.1%) | ||
| 4 | 0 (0.0%) | 0 (0.0%) | 3 (0.9%) | 1 (2.0%) | ||
| Medication class | ||||||
| Cyclophosphamide | 7 (4.0%) | 9 (8.0%) | 0.16 | 15 (4.5%) | 8 (16.3%) | 0.001 |
| Azathioprine | 9 (5.2%) | 10 (8.9%) | 0.23 | 13 (3.9%) | 3 (6.1%) | 0.47 |
| Mycophenolate mofetil | 25 (14.5%) | 23 (20.5%) | 0.19 | 36 (10.8%) | 5 (10.2%) | 0.90 |
| Corticosteroids | 80 (46.2%) | 82 (73.2%) | <0.001 | 177 (53.2%) | 42 (85.7%) | <0.001 |
| RAAS blockade | 116 (67.1%) | 70 (62.5%) | 0.36 | 295 (88.6%) | 43 (87.8%) | 0.86 |
Immunosuppression use at or before enrollment visit.
Missing medication data for 2 patients.